Washington House passes FDA bill to move medicine testing beyond animals

The US House passed the FDA Modernisation Act 3.0, directing the FDA to update regulations to permit non-animal testing methods for drug development, building on the 2022 Act that removed the mandatory animal testing requirement. The bill now heads to the Senate and could reshape drug development timelines, costs, and safety testing accuracy.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.